RxDoctor Payments Data

Mahsa Massumi, MD

Hospitalist · Houston, TXNPI 1568719805

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,235 of the $5,033 with a category attached, or 84.2%. 14 manufacturers reported payments, led by Medtronic at 32.1% of the total. Reporting peaked in 2024 at $1,483 and has fallen 87.3% since, to $188 in 2025. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,033in general payments, 2019–2025

Across 59 payments — averaging $85.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Abiomed$1K
  • Abbott$905
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$474
  • Cardiovascular Systems Inc.$171
  • Angiodynamics, Inc.$167
  • plus $570 from 8 others

What the payments were for

  • Travel & lodging$79716%
  • Food & beverage$4,23584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,033 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.

See all hospitalist providers in Texas

Medicare billing

Part B allowed, 2024
$43,706
Medicare patients
133
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amiodarone Hcl19$428
Atorvastatin Calcium20$219
Amlodipine Besylate22$189
Pantoprazole Sodium13$151
Metoprolol Tartrate13$135
ClopidogrelClopidogrel Bisulfate11$123
Metoprolol Succinate15$114
Furosemide12$110
Carvedilol16$107
Losartan Potassium11$79
Levofloxacin11$44

Paid to pharmacies, not to this prescriber.

Other hospitalist in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →